OP-ED: New Alzheimer’s Drugs Don’t Deserve the Hype
A prominent childhood memory is of my grandparents living with and then dying from dementia. As is universal with dementia, there was a double…
A prominent childhood memory is of my grandparents living with and then dying from dementia. As is universal with dementia, there was a double…
Dementia is most widely associated with its cognitive symptoms, like memory loss. But it often brings a host of behavioral symptoms, too, like agitation…
Alzheimer’s disease affects one in every three people over the age of 85, and the scale of the epidemic is only worsening. While there…
In January of 2023, the Food and Drug Administration approved the second anti-amyloid therapy for Alzheimer’s disease, Leqembi (generic name lecanemab). A new Alzheimer’s…
Over 55 million people worldwide have dementia. This mind-robbing condition has a huge impact on society and the economy, so scientists are working hard…
I’m writing from Amsterdam, where this past week, the Being Patient editorial team has been reporting on the biggest news from the Alzheimer’s Association…
After almost two decades of stagnation, two new drugs for Alzheimer’s have hit the market in the last three years. The approval of Biogen…
Drugmaker Alzheon is currently running clinical trials on a new disease-modifying Alzheimer’s treatment: valiltramiprosate, or ALZ-801. While, like the new buzzy new Alzheimer’s monoclonal…
This article was made possible through sponsorship by Lexeo Therapeutics. Being Patient’s editorial team produced the interview and article with no review/approval process by the…
American pharmaceutical company Eli Lilly announced in May 2023 that it had seen encouraging clinical trial results of its new Alzheimer’s medication. According to…
This article was made possible through sponsorship by Lexeo Therapeutics. Being Patient’s editorial team produced the interview and article, with no review/approval process by…
On July 6, 2023, the U.S. Food and Drug Administration fully approved the Alzheimer’s drug Leqembi (generic name lecanemab), a monoclonal antibody drug for…
The brain’s neurons communicate with each other through chemical and electrical signals. But as Alzheimer’s disease develops, protein plaques and deposits buildup and kill…
Alzheimer’s is so far incurable, but there are medications out there that can help manage symptoms and improve quality of life for patients and…
Since the United States imposed an embargo on Cuba in 1961, the island nation has built a robust healthcare system on their own, with…